PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
175.10%
G&A change of 175.10% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
-94.58%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-14.44%
Operating expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-14.44%
Total costs reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
4.10%
Interest expense change of 4.10% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
14.44%
EBITDA change of 14.44% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
14.44%
Income change of 14.44% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.51%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
12.51%
Income change of 12.51% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
12.37%
EPS change of 12.37% versus flat Healthcare. Walter Schloss would verify quality.
12.37%
Diluted EPS change of 12.37% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.